TNTadahiro Nozoe

Tadahiro Nozoe

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Tadahiro Nozoe has a total of 17 co-authors. Here are the top co-authors by number of shared publications:

  • Kenji Sugio

    University of Occupational and Environmental Health

    4 shared publications
  • Kosei Yasumoto

    University of Occupational and Environmental Health

    4 shared publications
  • Takeshi Hanagiri

    University of Occupational and Environmental Health

    4 shared publications
  • Tsunehiro Oyama

    Authors' Affiliation: Second Department of Surgery, University of Occupational and Environmental Health, Kitakyushu, Japan

    3 shared publications
  • Emiko Mori

    Fukuoka Higashi Medical Center

    2 shared publications
  • Mitsuhiro Takenoyama

    Authors' Affiliation: Second Department of Surgery, University of Occupational and Environmental Health, Kitakyushu, Japan

    2 shared publications

Latest Publications

    • 1 December 2007
      • Vol. 54  (80) , 2272-5

    Experimental evidence for the efficacy of combined therapy of CPT-11 and hyperthermia for squamous cell carcinoma of the esophagus.

    by Tadahiro Nozoe, Mitsuhiro Yasuda, Masayuki Honda, Sadaaki Imutsuka, Daisuke Korenaga

    The aim of the current study was to show an anti-tumor effect for esophageal squamous carcinoma cells derived from a combination of hyperthermia and CPT-11, which would ultimately lead to the clinical usage of this therapeutic modality for patients with squamous cell carcinoma of the esophagus. Survival fraction of esophageal squamous carcinoma cells after administrating SN-38, active metabolite of CPT-11, and combination of hyperthermia and SN-38 was compared using data measured by MTT assay. Reduction of cell survival fraction derived by simultaneous induction of hyperthermia and SN-38, in many combinations of the temperature and charging period, was significantly greater than that acquired by SN-38 alone. Combination of hyperthermia and CPT-11 can exert a synergic anti-tumor efficacy for SCC of the esophagus.

  • Pancreatic endocrine carcinoma presenting with gastric varices derived by left-sided portal hypertension: a case report

    by Tadahiro Nozoe, Takeshi Hanagiri, Kenji Sugio, Kosei Yasumoto

  • Significance of Immunohistochemical Expression of Estrogen Receptors α and β in Squamous Cell Carcinoma of the Esophagus

    by Tadahiro Nozoe, Tsunehiro Oyama, Mitsuhiro Takenoyama, Takeshi Hanagiri, Kenji Sugio, Kosei Yasumoto

    Purpose: Possible significance of sex hormone estrogen as an antitumor therapeutic arm toward esophageal squamous cell carcinoma (ESCC) cells has been suggested. The aim of the current study was to clarify the clinicopathologic significance of an immunohistochemical expression of estrogen receptors α and β (ERα and ERβ) in ESCC. Experimental Design: Expression of ERα and ERβ were examined using an immunohistochemical methods in 73 paraffin-embedded sections collected from patients with ESCC who had been subjected to esophageal resection and digestive reconstruction without any preoperative induction therapy. Results: Forty-seven (64.4%) ESCCs had a positive cytoplasmic expression of ERα and 21 (28.8%) ESCCs had a positive nuclear expression of ERβ. Univariate analysis showed that both positive ERα expression (P = 0.0001) and negative ERβ expression (P = 0.026) were unfavorable prognostic indicators in ESCC. Moreover, multivariate analysis showed that ERα-positive/ERβ-negative expression (P = 0.003) and progression of tumor stage (P = 0.014) were found to be independent unfavorable prognostic indicators in ESCCs. Conclusions: Immunohistochemical expression of ERα and ERβ were found to be observed in ESCC. Positive expression of ERα in addition to negative expression of ERβ proved to be an unfavorable independent prognostic indicator in ESCC.


  • Clinicopathologic significance of an immunohistochemical expression of p27 in scirrhous carcinoma of the breast

    by Tadahiro Nozoe, Tsunehiro Oyama, Emiko Mori, Hidetaka Uramoto, Mitsuhiro Takenoyama, Takeshi Hanagiri, Kenji Sugio, Kosei Yasumoto

    Background: Scirrhous carcinoma has been known to have more aggressive biological behavior than other histologic subtypes of invasive ductal carcinoma of the breast. The significance of expression of p27kip1, which is thought to be a tumor suppressor gene, in breast carcinoma remains controversial. The aim of the current study was to clarify clinicopathologic significance of scirrhous carcinoma of the breast with special reference to p27 expression. Methods: Clinicopathologic features including immunohistochemical expression of p27 were compared between scirrhous carcinoma (n = 42) and non-scirrhous invasive ductal carcinoma (papillotubular and solid-tubular carcinoma, n = 63) of the breast. Results: The proportion of pathologic lymph node metastasis among scirrhous carcinomas was significantly higher than that among carcinomas of other histologic types (papillotubular or solid-tubular carcinomas, p = 0.029). The proportion of strong expression of p27 among scirrhous carcinomas was significantly lower than that among tumors of other histologic types (p > 0.0001). Conclusions: Biological behavior of scirrhous carcinoma was found to be aggressive. The aggressiveness and poor cellular differentiation of scirrhous carcinoma of the breast might be related to low p27 expression.


  • Increase in both CEA and CA19-9 in sera is an independent prognostic indicator in colorectal carcinoma

    by Tadahiro Nozoe, Tatsuya Rikimaru, Emiko Mori, Toshiro Okuyama, Ikuo Takahashi

    Background and Objectives Carcinoembryonic antigen (CEA) and carbohydrate antigen (CA19-9) are well known to be the most common tumor markers of colorectal carcinomas. However, the significance of increase in these markers to predict the prognosis of the patients remains a problem for debate. Methods One hundred three patients with colorectal carcinoma, who had been treated by resection and reconstruction of digestive tracts were studied. Correlation of preoperative serum value of CEA and CA19-9 with clinicopathologic features including prognosis of the patients was investigated. Results Preoperative elevation of both of the two markers proved to be an independent prognostic indicator, however, an elevation of only one of the two markers did not obtain a prognostic significance. Conclusions Combined data of preoperative increase in CEA and CA19-9 in sera can provide a powerful and useful information to predict prognosis of patients with colorectal carcinoma. J. Surg. Oncol. 2006;94:132–137.


    • 2 March 2006
      • Vol. 53  (67) , 73-6

    Over-expression of p53 protein in esophageal squamous cell carcinoma of women.

    by Tadahiro Nozoe, Yoshihiko Maehara

    Most physicians naturally accept the etiological aspect that the incidence of esophageal squamous cell carcinoma (ESCC) is excessively more frequent in men than that in women. However, a definitely scientific confirmation to explain it has not been found. In the current study, we investigated the relationship between gender and p53 over-expression, which might resolve the difference between the genders in the mechanism for carcinogenesis in ESCC. Immunohistochemical expression of p53 was examined for 134 ESCCs, and the correlation of the gender with the clinicopathologic features and over-expression of p53 was compared. The proportion of p53 over-expression in women was 23.8% (5 out of 21) and this incidence proportion was significantly lower than that in men (48.7%, 55 out of 113; p=0.031). This biological modulation might be correlated with the lower incidence of ESCC in women.


  • Significance of Immunohistochemical Expression of p27 and Involucrin as the Marker of Cellular Differentiation of Squamous Cell Carcinoma of the Esophagus

    by Tadahiro Nozoe, Tsunehiro Oyama, Mistuhiro Takenoyama, Takeshi Hanagiri, Kenji Sugio, Kosei Yasumoto

    Purpose: p27kip1 belongs to the KIP/CIP family of cyclin-dependent kinase inhibitors and is considered to be a tumor suppressor. Involucrin has been known as a marker of differentiation of squamous cell carcinoma (SCC). The aim of this study was to evaluate the clinicopathologic significance of the expression of p27 and involucrin in esophageal SCC. Methods: Immunohistochemical expression of p27 and involucrin was examined in 70 specimens of esophageal SCC. The correlation of the expression of these proteins and clinicopathologic features was evaluated. Results: Cellular differentiation in esophageal SCC was significantly correlated with the expression of p27 and involucrin (p = 0.010 and p = 0.002, respectively). Among well, moderately and poorly differentiated SCCs, 45.8 ± 21.6, 20.0 ± 15.0 and 10.6 ± 9.1% of carcinoma cells expressed involucrin, respectively (p < 0.0001 for well vs. poorly, p < 0.0001 for well vs. moderately, and p = 0.042 for moderately vs. poorly). There existed a more powerful statistical difference regarding the histological grade between SCCs with the expression of both p27 and involucrin and tumors with other expression patterns (p = 0.0001). Conclusions: Expression of both p27 and involucrin can be a powerful biological marker of cellular differentiation of esophageal SCC.


  • Open Access

    Preoperative sorting of circulating T lymphocytes in patients with esophageal squamous cell carcinoma: Its prognostic significance

    by Tadahiro Nozoe, Yoshihiko Maehara, Keizo Sugimachi

    AIM: To elucidate the immunologic parameters for the outcome of patients with malignant tumors, especially esophageal squamous cell carcinoma (ESCC) associated with high malignant potential. METHODS: Clinicopathologic features were compared between patients with lower and higher CD4 and CD8 values as well as CD4/CD8 ratio in peripheral blood. RESULTS: The survival rate of patients with higher CD4 value was significantly better than that in patients with lower CD4 value (P = 0.039). The survival rate of patients with higher CD8 value was significantly worse than that of patients with lower CD8 value (P = 0.026). Similarly, the survival rate of patients with higher CD4/CD8 ratio was significantly better than that of patients with lower CD4/CD8 ratio (P = 0.042). Additionally, multivariate analysis demonstrated that lower CD8 and lower CD4/CD8 ratio were factors independently associated with worse prognosis of patients. CONCLUSION: All the immunologic parameters can predict the outcome of patients with ESCC.